These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1618265)
1. Differential inhibition by the PAF receptor antagonist, WEB 2170, of allergic inflammation in single sensitized and boosted mice. Amorim CZ; Martins MA; Cordeiro RS; Vargaftig BB Eur J Pharmacol; 1992 Jan; 211(1):29-33. PubMed ID: 1618265 [TBL] [Abstract][Full Text] [Related]
2. Involvement of platelet-activating factor in death following anaphylactic shock in boosted and in unboosted mice. Amorim CZ; Cordeiro RS; Vargaftig BB Eur J Pharmacol; 1993 Apr; 235(1):17-22. PubMed ID: 8519279 [TBL] [Abstract][Full Text] [Related]
3. Interference of PCA 4248, a novel PAF receptor antagonist, with antigen-induced paw edema in mice. Amorim CZ; Cordeiro RS; Vargaftig BB Eur J Pharmacol; 1993 May; 236(2):301-4. PubMed ID: 8319756 [TBL] [Abstract][Full Text] [Related]
4. Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse. Henriques MG; Weg VB; Martins MA; Silva PM; Fernandes PD; Cordeiro RS; Vargaftig BB Br J Pharmacol; 1990 Jan; 99(1):164-8. PubMed ID: 2331569 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914 [TBL] [Abstract][Full Text] [Related]
6. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats. Martins MA; Castro Faria Neto HC; Bozza PT; e Silva PM; Lima MC; Cordeiro RS; Vargaftig BB J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149 [TBL] [Abstract][Full Text] [Related]
7. Interference of antihistamines and anti-allergic drugs with antigen-induced paw edema in boosted and unboosted mice. Amorim CZ; Cordeiro RS; Vargaftig BB Eur J Pharmacol; 1992 Jun; 216(3):429-34. PubMed ID: 1358629 [TBL] [Abstract][Full Text] [Related]
8. WEB 2086, a novel specific PAF antagonist, prevents PAF induced arrhythmogenicity. Mest HJ; Riedel A; Rein T Pharmacol Res; 1990; 22(4):445-53. PubMed ID: 2402478 [TBL] [Abstract][Full Text] [Related]
9. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086. Desquand S; Lefort J; Dumarey C; Vargaftig BB Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029 [TBL] [Abstract][Full Text] [Related]
10. Involvement of leukotrienes in allergic inflammation in mice. Zuany-Amorim C; Cordeiro RS; Vargaftig BB Eur J Pharmacol; 1994 May; 257(3):211-6. PubMed ID: 7916299 [TBL] [Abstract][Full Text] [Related]
11. Enterolobin induces rat paw oedema independently of PAF-acether. Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor. Terasawa M; Aratani H; Setoguchi M; Tahara T Prostaglandins; 1990 Dec; 40(6):553-69. PubMed ID: 2093935 [TBL] [Abstract][Full Text] [Related]
13. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis. Casals-Stenzel J Immunopharmacology; 1987 Apr; 13(2):117-24. PubMed ID: 3597059 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170). Heuer HO Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975 [TBL] [Abstract][Full Text] [Related]
15. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs. Heuer HO Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736 [TBL] [Abstract][Full Text] [Related]
16. Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts. Vleeming W; Wemer J; Porsius AJ J Cardiovasc Pharmacol; 1992; 20(5):790-9. PubMed ID: 1280743 [TBL] [Abstract][Full Text] [Related]
17. Effects of a novel PAF antagonist, E6123, on passive anaphylaxis. Sakuma Y; Tsunoda H; Katayama S; Harada K; Obaishi H; Shirato M; Yamada K; Miyazawa S; Okano K; Machida Y Agents Actions Suppl; 1990; 31():255-8. PubMed ID: 2080758 [TBL] [Abstract][Full Text] [Related]
18. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs. Heuer HO J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086 [TBL] [Abstract][Full Text] [Related]
19. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. Desquand S; Lefort J; Dumarey C; Vargaftig BB Br J Pharmacol; 1991 Mar; 102(3):687-95. PubMed ID: 1285397 [TBL] [Abstract][Full Text] [Related]
20. Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice. Herbert JM; Lespy L; Maffrand JP Eur J Pharmacol; 1991 Dec; 205(3):271-6. PubMed ID: 1817964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]